Clinical Trial Update: Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intratumoral administration of Daromun in basal cell carcinoma and cutaneous squamous cell carcinoma (non-melanoma skin cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• DAROMUN

Snippet

Sponsor: Philogen S.p.A. | Conditions: Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell | Phase 2 | Status: UNKNOWN